Institute of Science Tokyo · Graduate School of Medical and Dental Sciences

Research keywordsmultisystem inflammatory syndrome in children・refractory COVID-19・infliximab therapy・pediatric immunology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yamaguchi Y, Takasawa K, Irabu H, Hiratoko K, Ichigi Y, Hirata K, Tamura Y, Murakoshi M, Yamashita M, Nakatani H, Shimoda M, Ishii T, Udagawa T, Shimizu M, Kanegane H, Morio T. Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2022.01; ( PubMed , DOI )2022

• Official profile